In our study we reported that DEX/VitD2-generated tolDCs from patients with euglycemia, but not hyperglycemia, markedly reduced not only primary Th1/Th17 responses, but also mature DC-induced proinflammatory IFN- γ, IL-17, TNF-α, and IL-9 production. This evidence concerns the gene IL17A and Hyperglycemia.